Loading the company…
Loading the company…
㈜트리아펙스
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2007. Industry: Medical & Precision Devices. Revenue for 2025 was ₩19.1bn. It has 57 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2016-04-28 · latest registration 2019-11-28 · newest first
본 발명은 편광 필름, 이의 제조 방법, 및 이를 포함하는 편광 렌즈에 관한 것으로, 보다 상세하게는, 광학적, 기계적 물성이 우수하고, 가공 공정에서 충분한 마진을 확보할 수 있으면서도, 색상 재현성이 우수하고 경시적 변화가 적은, 편광 필름, 이의 제조 방법, 및 이를 포함하는 편광 렌즈에 관한 것이다.
본 발명은 편광필름, 편광렌즈 및 이의 제조방법에 관한 것이다. 본 발명에서는 TAC 필름(22)의 표면에는 코팅처리에 의해 코팅막(24)이 형성된다. 그리고, 폴리비닐알코올 필름(20)의 양면에 TAC 필름(22)이 부착된다. 상기 TAC 필름(22)은 상기 폴리비닐알코올 필름(20)을 보호하기 위해 부착된다. 상기 코팅막(24)이 형성된 TAC 필름(22)의 표면에는 각각 CR39(30)가 부착된다. 한편, 상기 코팅처리는 바람직하게 슬롯다이 방식에 의해 이루어진다. 이와 같은 본 발명에 의하면, CR39 단일체와 TAC 필름의 접착성이 향상되기 때문에 CR39 단일체가 쉽게 분리되는 것이 방지되어 제품의 내구성이 향상되는 효과가 있다. 편광렌즈, TAC 필름
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 17.7 | 19.1 |
| Cost of sales | 11.0 | 11.9 |
| Gross profit (loss) | 6.7 | 7.2 |
| Selling, general and administrative expenses | 3.5 | 4.0 |
| Operating income (loss) | 3.1 | 3.2 |
| Non-operating income | 0.4 | 0.4 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.1 | 0.1 |
| Other | 0.3 | 0.3 |
| Non-operating expenses | 0.4 | 0.5 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.1 | 0.2 |
| Other | 0.2 | 0.3 |
| Profit (loss) before tax | 3.2 | 3.1 |
| Income tax expense | 0.3 | 0.4 |
| Net income (loss) | 2.9 | 2.7 |
Revenue ₩19.1bn, up 7.9% YoY.
Operating margin 16.6% (prior 17.7%).
Net income ₩2.7bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06